Skip to main content

BFSG, LLC

Position in NVO — Novo Nordisk A S

CIK 1706836 IRVINE, CA

Position in NVO

as of Jun 30, 2026 · filed Jul 20, 2026
Position Value
$586,929
-$1,220,399 QoQ
Shares Held
12,243
-75.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#197
of 478 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BFSG, LLC holds $27,089,521 across 12 Drug Manufacturers - General names. NVO ranks #7 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
12,243 $586,929

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $586,929 12,243
2026-03-31 $1,807,328 49,179
2025-12-31 $2,507,875 49,290
2025-09-30 $6,878,762 123,964
2025-06-30 $8,106,399 117,450
2025-03-31 $8,020,806 115,507
2024-12-31 $8,859,371 102,992
2024-09-30 $10,313,486 86,617
2024-06-30 $6,274,136 43,955
2024-03-31 $5,976,378 46,545
2023-12-31 $4,836,701 46,754
2023-09-30 $4,248,534 46,718
2023-06-30 $3,514,947 21,720
2023-03-31 $2,934,223 18,438
2022-12-31 $2,499,459 18,468
2022-09-30 $1,882,309 18,893
2022-06-30 $2,153,161 19,323
2022-03-31 $2,174,025 19,577
2021-12-31 $2,292,752 20,471
2021-09-30 $2,076,312 21,626
2021-06-30 $1,839,672 21,961
2021-03-31 $1,554,300 23,054
2020-12-31 $2,001,062 28,648
2020-09-30 $2,028,258 29,213
2020-06-30 $1,967,674 30,050
2020-03-31 $1,815,030 30,150